Exfoliative dermatitis
☆ Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Red (burning) Skin Syndrome ― Erythema uye chikero pamuviri wese ndizvo zviratidzo zvikuru zveExfoliative dermatitis.
References
Erythroderma isingawanzo asi yakakomba ganda mamiriro. Kunyange zvazvo chikonzero chaicho chisingawanzozivikanwa, chinogona kukonzerwa nekuita kwezvinodhaka kana kenza iri pasi. Imwe kenza yakajairika yakabatana ne exfoliative dermatitis ndeye cutaneous T-cell lymphoma, iyo inogona kusaratidza zviratidzo kwemwedzi kana makore mushure mekutanga kweganda. Kazhinji, kuchipatara kunodiwa kuongororwa kwekutanga uye kurapwa. Varwere vane chirwere chinokonzerwa nezvinodhaka kazhinji vane maonero akanaka enguva refu, kunyange zvazvo nyaya dzisina chikonzero chakajeka dzinowanzoita nzira inodzokororwa uye yekudzorera. Kufanotaura kwezviitiko zvine chekuita negomarara kazhinji zvinoenderana nekuti cancer inofamba sei.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Iyo inowanzo ratidza kutsvuka kwakapararira uye kuputika kufukidza pamusoro pe90% yemuviri. Ichi chimiro chiratidzo chinooneka chezvakasiyana-siyana zvehutano zvine chekuita senge psoriasis, eczema, kana mhinduro kune mimwe mishonga.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Chinonyanya kukonzera erythroderma ndiko kuwedzera kwechirwere cheganda chepasi, chakadai se psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris kana kushandiswa kwezvinodhaka, zvakadai sekushandisa topical steroids. Primary manefestation haina kuwanda uye inowanzoonekwa muzviitiko zvecutaneous T-cell lymphoma. Nokuti zvakakosha kuisiyanisa kubva kune cutaneous T cell lymphoma, biopsy inoitwa.